WASHINGTON -- Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced clinical trial results from RECOVER RIGHT, an Investigational Device Exemption (IDE) study of ...
The second issue of the open-access journal showcases multidisciplinary heart failure research and the many intersections that shape patient care. This issue showcases multidisciplinary heart failure ...
An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journal of the American College of ...
Luís Beck-da-Silva, MD; Adolfo de Bold, PhD, FRSC; Ross A. Davies, MD, FRCPC; Benjamin J.W. Chow, MD, FRCPC; Terrence D. Ruddy, MD, FRCPC; Margaret Fraser, RN ...
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) announces that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s ...
CLEVELAND, University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in the state of Ohio to implant a revolutionary device to treat right ...
Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...
Onlymyhealth on MSN
Can heart failure be reversed? Experts explain
Heart failure is a global health issue. There is a common notion that heart failures can cause permanent damage and can never ...
Arrhythmogenic right ventricular cardiomyopathy is a life threatening genetic heart condition that causes problems with the muscle tissue around your heart’s right ventricle. Arrhythmogenic right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results